Crisaborole for adults, adolescents and children with atopic dermatitis
NIHR HSRIC
Record ID 32016000643
English
Authors' objectives:
Atopic dermatitis, also known as eczema, is a long term condition that affects the skin. People with atopic dermatitis have sore, dry skin that causes intense itching, which can ooze and weep. This can lead to skin infections and trouble sleeping. It usually starts in infancy and can sometimes last into adulthood.
Crisaborole is a new anti-inflammatory cream for atopic dermatitis. Some studies have suggested that crisaborole can improve the symptoms of atopic dermatitis. If crisaborole is licensed for use in the UK, it could be a new treatment option for patients with atopic dermatitis.
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hsric.nihr.ac.uk/topics/crisaborole-for-adults-adolescents-and-children-with-atopic-dermatitis/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Dermatologic Agents
- Adolescent
- Adult
- Child
- Dermatitis, Atopic
- Bridged Bicyclo Compounds, Heterocyclic
- Boron Compounds
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Centre (NIHR HSC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.